A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator’s Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Principal investigator: Sirpa Leppä
Trial site: HUS Comprehensive Cancer Center

Link to the ClinicalTrials.gov study website